Skip to main content
Presentation
Sepsis and pancreatic cancer: Biliary stents a significant risk factor in patients undergoing chemotherapy.
Journal of Clinical Oncology (2021)
  • Charles Charles Li, RenovoRx, Los Altos, CA;
  • Amer H. Zureikat, University of Pittsburgh
  • Paula M. Novelli, University of Pittsburgh
  • Charles D. Lopez, Oregon Health & Science University
  • Adel Kardosh, Oregon Health & Science University
  • Ki Y. Chung, Institute for Translational Oncology Research, Prisma Health-Upstate Cancer Institute, Greenville, SC;
  • Aron Michael Devane, Greenville Health System
  • Hassan Hatoum, University of Oklahoma Health Sciences Center
  • Kenneth Lee Meredith, Florida State University
  • Emmanuel E. Zervos, East Carolina University
  • Antonio Ucar, Miami Cancer Institute, Miami, FL;
  • Ripal T Gandhi, Miami Cardiac and Vascular Institute, Miami, FL;
  • Reza Nazemzadeh, Levine Cancer Institute, Atrium Health, Charlotte, NC;
  • Pashtoon Murtaza Kasi, University of Iowa
  • Jochen Decaestecker, AZ Delta, Roeselare, Belgium;
  • Erik Vandestraeten, AZ Maria Middelares, Gent, Belgium;
  • Thierry Delaunoit, CHR Jolimont, La Louvière, Belgium;
  • Shahriar Sharif, RenovoRx, Los Altos, CA;
  • Ramtin Agah, El Camino Hospital
  • Michael J. Pishvaian, Johns Hopkins University School of Medicine
Publication Date
January 22, 2021
DOI
10.1200/JCO.2021.39.3_SUPPL.399
Citation Information
Charles Charles Li, Amer H. Zureikat, Paula M. Novelli, Charles D. Lopez, et al.. "Sepsis and pancreatic cancer: Biliary stents a significant risk factor in patients undergoing chemotherapy." Journal of Clinical Oncology (2021)
Available at: http://works.bepress.com/antonio-ucar/28/